Skip to main content

Indeterminate findings on imaging-guided biopsy: should additional intervention be pursued?

Dameron RD, deLong DM, Fisher AJ, DeLong DM, Dodd LG, Nelson RC

Publication: AJR Am J Roentgenol (1999) • Vol 173 • Page 461-4PMID: 10430154View on PubMed

Purpose

This paper investigated how biopsy needle-gauge, guidance method, number of passes and pathology findings may influence the rate of a follow-up malignancy diagnosis in indeterminate abdominal biopsies.

Conclusion

During follow-up, indeterminate lesions biopsied with Computed Tomography (CT)-guidance were more likely to be subsequently diagnosed as malignant than those biopsied under sonography guidance (49% versus 27.5%). Similarly, a follow-up malignant diagnosis was more likely than a benign diagnosis when the indeterminate biopsy contained atypical cells (71% versus 29%, p=0.008). The incidence of malignant diagnosis during follow-up was not significantly affected by the number of needle passes, needle gauge (G), tissue biopsied, lesion diameter or depth, or the presence of reactive cells in the initial biopsy.

Studies (1)

Purpose

This study investigated how biopsy needle-gauge, guidance method, number of passes and pathology findings may influence the rate of a follow-up malignancy in abdominal biopsies originally classified as indeterminate. The sample set comprised biopsies, originally classified as indeterminate (atypical or reactive cells without definite evidence of malignancy), that  were obtained from 91 abdominal lesions (35 liver, 28 pancreas, 6 adrenal, 4 kidney and 18 lymph nodes or spleen) by CT guidance (51 lesions) or sonography guidance (40 lesions).  Diagnosis was based on biopsy (58 cases), radiology (28 cases) or clinical follow-up in the 6-36 months following initial biopsy (28 cases). For cases where the follow-up diagnosis was malignant (36 cases including adenocarcinoma, mesothelioma, lymphoma, sarcoma and hemangioendothelioma) the biopsy was considered to be a false negatives, and a follow-up diagnosis of benign (55 cases) constituted a true negative. Initial indeterminate biopsies were performed with a 20 or 22-G self-aspirating needle (56 lesions) or an 18-G automated spring-loaded cutting needle (35 cases) and included 1-5 passes. Details of specimen processing were not specified and assumed to include formalin fixation and H&E staining.

Summary of Findings

False negatives occurred more frequently in biopsies obtained by CT guidance than by sonography-guidance (49% versus 27.5%, p=0.037). Atypical cells occurred more frequently in biopsies that were classified as false-negative than those classified as a true negative (71% versus 29%, p=0.008), but reactive cells were present in comparable proportions. False negative rate was not significantly affected by the number of needle passes, needle gauge, tissue biopsied, lesion diameter or lesion depth.

  • Biospecimens

    TissueAdrenal Gland
    TissueKidney
    TissueLiver
    TissueLymph Node
    TissuePancreas
    TissueSpleen
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticBenign
    NeoplasticCarcinoma
    NeoplasticSarcoma
    NeoplasticLymphoma
    NeoplasticOther
  • Platforms

    MorphologyLight microscopy
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Adrenal
    Kidney
    Liver
    Pancreas
    Spleen or lymph
    Biospecimen AcquisitionMethod of tissue acquisition
    CT-guided biopsy
    Sonography-guided
    Biospecimen AcquisitionNeedle gauge
    18-G automated spring-loaded cutting needle
    20 or 22-G self-aspirating needle
    Biospecimen Aliquots and ComponentsAliquot size/volume
    1-5 passes
    Biospecimen Aliquots and ComponentsBiospecimen heterogeneity
    Intratumoral sampling (exact positions not specified)